Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and  drug delivery
Anti-cancer drug gets phase I FDA trials approval
New mass spec platform launched
Approval for prostate cancer treatment
Base to Base biotech podcast 25: Molecular glue degradation
Personalis reveals new data from lung cancer trial
iNtRON Bio files gene editing patents
CAGE Bio collaborating to advance treatments for cutaneous graft versus host disease
D3 Bio gets KRAS G12C-mutated cancers boost
Raina Biosciences unveils generative AI platform for mRNA therapeutics
Menin: A new target for bladder cancer
Hongene to supply exNA oligonucleotide technology under new licensing deal